Read the most important and the latest news about CERVANTES trial here

I. CERVANTES study (protocol version v2.0) was authorised through Clinical Trial Information System (CTIS) in Austria, Belgium, Italy, Poland and Spain.

• Austria - 5 sites

• Belgium - 6 sites

• Italy - 1 site

• Poland - 5 sites First clinical site is opened for CERVANTES in Poland

• Spain - 12 sites - 5 opened sites (first two Spanish patients were enroled from 2 sites)

II. 3 Brazilian Clinical Sites approved by International Review Board (IRB)

III. Slovakia and Romania are in preparation for CTIS authorisation

IV. Preparation for CTIS registration of new Italian clinical sites in collaboration with MaNGO group (IT)

V. 60 patients enrolled from 15 recruiting centres in 10 countries - 9 more sites are waiting for their first patient